In the first quarter of this year, Vermillion, Inc. (NasdaqGM: VRML) paid us the last installment of $150,000 of the $600,000 settlement for using Health Discovery Corporation's Support Vector Machines patented technology in the development of OVA1 ovarian cancer triage test, which has been recently brought to market by Vermillion and Quest Diagnostics.
We remain vigilant and are waiting for the appropriate time to pursue possible infringement claims when products are commercialized and we can identify damages.
Market Data 
Markets 
AI
